{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:29:10Z","timestamp":1794047350105,"version":"4.8.0"},"reference-count":47,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"2","license":[{"start":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T00:00:00Z","timestamp":1578528000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>Severe combined immunodeficiencies (SCIDs) constitute a heterogeneous group of life-threatening genetic disorders that typically present in the first year of life. They are defined by the absence of autologous T cells and the presence of an intrinsic or extrinsic defect in the B-cell compartment. In three newborns presenting with frequent infections and profound leukopenia, we identified a private, heterozygous mutation in the RAC2 gene (p.G12R). This mutation was de novo in the index case, who had been cured by hematopoietic stem cell transplantation but had transmitted the mutation to her sick daughter. Biochemical assays showed that the mutation was associated with a gain of function. The results of in vitro differentiation assays showed that RAC2 is essential for the survival and differentiation of hematopoietic stem\/progenitor cells. Therefore, screening for RAC2 gain-of-function mutations should be considered in patients with a SCID phenotype and who lack a molecular diagnosis.<\/jats:p>","DOI":"10.3324\/haematol.2019.230250","type":"journal-article","created":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T12:14:22Z","timestamp":1578572062000},"page":"404-411","source":"Crossref","is-referenced-by-count":32,"title":["A gain-of-function RAC2 mutation is associated with bone-marrow hypoplasia and an autosomal dominant form of severe combined immunodeficiency"],"prefix":"10.3324","volume":"106","author":[{"family":"Chantal Lagresle-Peyrou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Aur\u00e9lien Olichon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Hanem Sadek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Philippe Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Claudine Tardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Cindy Da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Alexandrine Garrigue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Alain Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Despina Moshous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Yves Collette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Capucine Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Jean Laurent Casanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Isabelle Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Marina Cavazzana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2020,1,9]]},"reference":[{"key":"19882","doi-asserted-by":"crossref","unstructured":"Cavazzana M, Bushman FD, Miccio A, Andr\u00e9-Schmutz I, Six E. Gene therapy targeting haematopoietic stem cells for inherited diseases: progress and challenges. Nat Rev Drug Discov. 2019; 18(6):447-462.","DOI":"10.1038\/s41573-019-0020-9"},{"key":"19883","doi-asserted-by":"crossref","unstructured":"Fischer A, Notarangelo LD, Neven B, Cavazzana M, Puck JM. Severe combined immunodeficiencies and related disorders. Nat Rev Dis Primers. 2015; 1(1):15061.","DOI":"10.1038\/nrdp.2015.61"},{"key":"19884","doi-asserted-by":"crossref","unstructured":"Picard C, Bobby Gaspar H, Al-Herz W. International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee Report on Inborn Errors of Immunity. J Clin Immunol. 2018; 38(1):96-128.","DOI":"10.1007\/s10875-017-0464-9"},{"key":"19885","doi-asserted-by":"crossref","unstructured":"de Vaal O, Seynhaeve V. Reticular dysgenesia. Lancet. 1959; 2(7112):1123-1125.","DOI":"10.1016\/S0140-6736(59)90105-9"},{"key":"19886","doi-asserted-by":"crossref","unstructured":"Pannicke U, H\u00f6nig M, Hess I. Reticular dysgenesis (aleukocytosis) is caused by mutations in the gene encoding mitochondrial adenylate kinase 2. Nat Genet. 2009; 41(1):101-105.","DOI":"10.1038\/ng.265"},{"key":"19887","doi-asserted-by":"crossref","unstructured":"Lagresle-Peyrou C, Six EM, Picard C. Human adenylate kinase 2 deficiency causes a profound hematopoietic defect associated with sensorineural deafness. Nat Genet. 2009; 41(1):106-111.","DOI":"10.1038\/ng.278"},{"key":"19888","doi-asserted-by":"crossref","unstructured":"Six E, Lagresle-Peyrou C, Susini S. AK2 deficiency compromises the mitochondrial energy metabolism required for differentiation of human neutrophil and lymphoid lineages. Cell Death Dis. 2015; 6:e1856.","DOI":"10.1038\/cddis.2015.211"},{"key":"19889","doi-asserted-by":"crossref","unstructured":"Troeger A, Williams DA. Hematopoieticspecific Rho GTPases Rac2 and RhoH and human blood disorders. Exp Cell Res. 2013; 319(15):2375-2383.","DOI":"10.1016\/j.yexcr.2013.07.002"},{"key":"19890","doi-asserted-by":"crossref","unstructured":"Nayak RC, Chang K-H, Vaitinadin N-S, Cancelas JA. Rho GTPases control specific cytoskeleton-dependent functions of hematopoietic stem cells. Immunol Rev. 2013; 256(1):255-268.","DOI":"10.1111\/imr.12119"},{"key":"19891","doi-asserted-by":"crossref","unstructured":"Gu Y, Filippi M-D, Cancelas JA. Hematopoietic cell regulation by Rac1 and Rac2 guanosine triphosphatases. Science. 2003; 302(5644):445-449.","DOI":"10.1126\/science.1088485"},{"key":"19892","unstructured":"Shirsat NV, Pignolo RJ, Kreider BL, Rovera G. A member of the ras gene superfamily is expressed specifically in T, B and myeloid hemopoietic cells. Oncogene. 1990; 5(5):769-772."},{"key":"19893","doi-asserted-by":"crossref","unstructured":"Gu Y, Byrne MC, Paranavitana NC. Rac2, a hematopoiesis-specific Rho GTPase, specifically regulates mast cell protease gene expression in bone marrowderived mast cells. Mol Cell Biol. 2002; 22(21):7645-7657.","DOI":"10.1128\/MCB.22.21.7645-7657.2002"},{"key":"19894","doi-asserted-by":"crossref","unstructured":"Andr\u00e9-Schmutz I, Le Deist F, Hacein-Bey-Abina S. Immune reconstitution without graft-versus-host disease after haemopoietic stem-cell transplantation: a phase 1\/2 study. Lancet. 2002; 360(9327):130-137.","DOI":"10.1016\/S0140-6736(02)09413-8"},{"key":"19895","doi-asserted-by":"crossref","unstructured":"Olson MF. Rho GTPases, their post-translational modifications, disease-associated mutations and pharmacological inhibitors. Small GTPases. 2018; 9(3):203-215.","DOI":"10.1080\/21541248.2016.1218407"},{"key":"19896","doi-asserted-by":"crossref","unstructured":"Ambruso DR, Knall C, Abell AN. Human neutrophil immunodeficiency syndrome is associated with an inhibitory Rac2 mutation. Proc Natl Acad Sci U S A. 2000; 97(9):4654-4659.","DOI":"10.1073\/pnas.080074897"},{"key":"19897","doi-asserted-by":"crossref","unstructured":"Accetta D, Syverson G, Bonacci B. Human phagocyte defect caused by a Rac2 mutation detected by means of neonatal screening for T-cell lymphopenia. J Allergy Clin Immunol. 2011; 127(2):535-538.e1-2.","DOI":"10.1016\/j.jaci.2010.10.013"},{"key":"19898","doi-asserted-by":"crossref","unstructured":"Alkhairy OK, Rezaei N, Graham RR. RAC2 loss-of-function mutation in 2 siblings with characteristics of common variable immunodeficiency. J Allergy Clin Immunol. 2015; 135(5):1380-1384.e1-5.","DOI":"10.1016\/j.jaci.2014.10.039"},{"key":"19899","doi-asserted-by":"crossref","unstructured":"Lougaris V, Chou J, Beano A. A monoallelic activating mutation in RAC2 resulting in a combined immunodeficiency. J Allergy Clin Immunol. 2019; 143(4):1649-1653.e3.","DOI":"10.1016\/j.jaci.2019.01.001"},{"key":"19900","doi-asserted-by":"crossref","unstructured":"Hsu AP, Donk\u00f3 A, Arrington ME. Dominant activating RAC2 mutation with lymphopenia, immunodeficiency, and cytoskeletal defects. Blood. 2019; 133(18):1977-1988.","DOI":"10.1182\/blood-2018-11-886028"},{"key":"19901","doi-asserted-by":"crossref","unstructured":"Sharapova SO, Haapaniemi E, Sakovich IS. Heterozygous activating mutation in RAC2 causes infantile-onset combined immunodeficiency with susceptibility to viral infections. Clin Immunol. 2019; 205:1-5.","DOI":"10.1016\/j.clim.2019.05.003"},{"key":"19902","doi-asserted-by":"crossref","unstructured":"Scheffzek K, Stephan I, Jensen ON, Illenberger D, Gierschik P. The Rac-RhoGDI complex and the structural basis for the regulation of Rho proteins by RhoGDI. Nat Struct Biol. 2000; 7(2):122-126.","DOI":"10.1038\/72392"},{"key":"19903","doi-asserted-by":"crossref","unstructured":"Hunter JC, Manandhar A, Carrasco MA, Gurbani D, Gondi S, Westover KD. Biochemical and structural analysis of common cancer-associated KRAS mutations. Mol Cancer Res. 2015; 13(9):1325-1335.","DOI":"10.1158\/1541-7786.MCR-15-0203"},{"key":"19904","doi-asserted-by":"crossref","unstructured":"Illenberger D, Walliser C, Strobel J. Rac2 regulation of phospholipase C-beta 2 activity and mode of membrane interactions in intact cells. J Biol Chem. 2003; 278(10):8645-8652.","DOI":"10.1074\/jbc.M211971200"},{"key":"19905","doi-asserted-by":"crossref","unstructured":"Reimann C, Six E, Dal-Cortivo L. Human T-lymphoid progenitors generated in a feeder-cell-Free delta-like-4 culture system promote T-cell reconstitution in NOD\/SCID\/\u03b3c\u2212\/\u2212 Mice. Stem Cells. 2012; 30(8):1771-1780.","DOI":"10.1002\/stem.1145"},{"key":"19906","doi-asserted-by":"crossref","unstructured":"Grimsley-Myers CM, Sipe CW, Wu DK, Lu X. Redundant functions of Rac GTPases in inner ear morphogenesis. Dev Biol. 2012; 362(2):172-186.","DOI":"10.1016\/j.ydbio.2011.12.008"},{"key":"19907","doi-asserted-by":"crossref","unstructured":"Mulloy JC, Cancelas JA, Filippi M-D, Kalfa TA, Guo F, Zheng Y. Rho GTPases in hematopoiesis and hemopathies. Blood. 2010; 115(5):936-947.","DOI":"10.1182\/blood-2009-09-198127"},{"key":"19908","doi-asserted-by":"crossref","unstructured":"Lor\u00e8s P, Morin L, Luna R, Gacon G. Enhanced apoptosis in the thymus of transgenic mice expressing constitutively activated forms of human Rac2GTPase. Oncogene. 1997; 15(5):601-605.","DOI":"10.1038\/sj.onc.1201378"},{"key":"19909","doi-asserted-by":"crossref","unstructured":"Tao W, Filippi M-D, Bailey JR. The TRQQKRP motif located near the C-terminus of Rac2 is essential for Rac2 biologic functions and intracellular localization. Blood. 2002; 100(5):1679-1688.","DOI":"10.1182\/blood.V100.5.1679.h81702001679_1679_1688"},{"key":"19910","doi-asserted-by":"crossref","unstructured":"Canman JC, Lewellyn L, Laband K. Inhibition of Rac by the GAP activity of centralspindlin is essential for cytokinesis. Science. 2008; 322(5907):1543-1546.","DOI":"10.1126\/science.1163086"},{"key":"19911","doi-asserted-by":"crossref","unstructured":"Normand G, King RW. Understanding cytokinesis failure. Adv Exp Med Biol. 2010; 676:27-55.","DOI":"10.1007\/978-1-4419-6199-0_3"},{"key":"19912","doi-asserted-by":"crossref","unstructured":"Verma V, Mogilner A, Maresca TJ. Classical and emerging regulatory mechanisms of cytokinesis in animal cells. Biology (Basel). 2019; 8(3)Google Scholar","DOI":"10.3390\/biology8030055"},{"key":"19913","doi-asserted-by":"crossref","unstructured":"Moulding DA, Moeendarbary E, Valon L, Record J, Charras GT, Thrasher AJ. Excess Factin mechanically impedes mitosis leading to cytokinesis failure in X-linked neutropenia by exceeding Aurora B kinase error correction capacity. Blood. 2012; 120(18):3803-3811.","DOI":"10.1182\/blood-2012-03-419663"},{"key":"19914","doi-asserted-by":"crossref","unstructured":"Zhang Q, Dove CG, Hor JL. DOCK8 regulates lymphocyte shape integrity for skin antiviral immunity. J Exp Med. 2014; 211(13):2549-2566.","DOI":"10.1084\/jem.20141307"},{"key":"19915","doi-asserted-by":"crossref","unstructured":"Al Ustwani O, Kurzrock R, Wetzler M. Genetics on a WHIM. Br J Haematol. 2014; 164(1):15-23.","DOI":"10.1111\/bjh.12574"},{"key":"19916","doi-asserted-by":"crossref","unstructured":"Moore AS, Wong YC, Simpson CL, Holzbaur ELF. Dynamic actin cycling through mitochondrial subpopulations locally regulates the fission-fusion balance within mitochondrial networks. Nat Commun. 2016; 7:12886.","DOI":"10.1038\/ncomms12886"},{"key":"19917","doi-asserted-by":"crossref","unstructured":"Capala ME, Maat H, Bonardi F. Mitochondrial dysfunction in human leukemic stem\/progenitor cells upon loss of RAC2. PLoS One. 2015; 10(5):e0128585.","DOI":"10.1371\/journal.pone.0128585"},{"key":"19918","doi-asserted-by":"crossref","unstructured":"Capala ME, Pruis M, Vellenga E, Schuringa JJ. Depletion of SAM50 specifically targets BCR-ABL-expressing leukemic stem and progenitor cells by interfering with mitochondrial functions. Stem Cells Dev. 2016; 25(5):427-437.","DOI":"10.1089\/scd.2015.0151"},{"key":"19919","doi-asserted-by":"crossref","unstructured":"Pei H, Zhang J, Nie J. RAC2-P38 MAPK-dependent NADPH oxidase activity is associated with the resistance of quiescent cells to ionizing radiation. Cell Cycle. 2017; 16(1):113-122.","DOI":"10.1080\/15384101.2016.1259039"},{"key":"19920","doi-asserted-by":"crossref","unstructured":"Nieborowska-Skorska M, Kopinski PK, Ray R. Rac2-MRC-cIII-generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors. Blood. 2012; 119(18):4253-4263.","DOI":"10.1182\/blood-2011-10-385658"},{"key":"19921","doi-asserted-by":"crossref","unstructured":"Je\u017eek J, Cooper KF, Strich R. Reactive oxygen species and mitochondrial dynamics: the yin and yang of mitochondrial dysfunction and cancer progression. Antioxidants (Basel). 2018; 7(1)Google Scholar","DOI":"10.3390\/antiox7010013"},{"key":"19922","doi-asserted-by":"crossref","unstructured":"Bigarella CL, Liang R, Ghaffari S. Stem cells and the impact of ROS signaling. Development. 2014; 141(22):4206-4218.","DOI":"10.1242\/dev.107086"},{"key":"19923","doi-asserted-by":"crossref","unstructured":"Ans\u00f3 E, Weinberg SE, Diebold LP. The mitochondrial respiratory chain is essential for haematopoietic stem cell function. Nat Cell Biol. 2017; 19(6):614-625.","DOI":"10.1038\/ncb3529"},{"key":"19924","doi-asserted-by":"crossref","unstructured":"Bunney TD, Opaleye O, Roe SM. Structural insights into formation of an active signaling complex between Rac and phospholipase C gamma 2. Mol Cell. 2009; 34(2):223-233.","DOI":"10.1016\/j.molcel.2009.02.023"},{"key":"19925","doi-asserted-by":"crossref","unstructured":"Edling CE, Pedersen M, Carlsson L, R\u00f6nnstrand L, Palmer RH, Hallberg B. Haematopoietic progenitor cells utilise conventional PKC to suppress PKB\/Akt activity in response to c-Kit stimulation. Br J Haematol. 2007; 136(2):260-268.","DOI":"10.1111\/j.1365-2141.2006.06434.x"},{"key":"19926","doi-asserted-by":"crossref","unstructured":"Elich M, Sauer K. Regulation of hematopoietic cell development and function through phosphoinositides. Front Immunol. 2018; 9:931.","DOI":"10.3389\/fimmu.2018.00931"},{"key":"19927","doi-asserted-by":"crossref","unstructured":"Smits BM, Lelieveld PHC, Ververs FA. A dominant activating RAC2 variant associated with immunodeficiency and pulmonary disease. Clin Immunol. 2019;108248.","DOI":"10.1016\/j.clim.2019.108248"},{"key":"19928","doi-asserted-by":"crossref","unstructured":"Notarangelo LD, Kim M-S, Walter JE, Lee YN. Human RAG mutations: biochemistry and clinical implications. Nat Rev Immunol. 2016; 16(4):234-246.","DOI":"10.1038\/nri.2016.28"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/9597\/70412","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/9597\/70413","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/9597\/70412","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T09:55:38Z","timestamp":1794045338000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/9597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,9]]},"references-count":47,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2019.230250","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1,9]]}}}